In one paragraphArticle in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Amirah Al Jawazneh *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0327-2832 Imke Liebold *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-9708-4735 Stephanie Leyk *I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0007-4600-3214 Clarissa LanzlothI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0006-9570-1935 Vera BrackrockI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0004-2076-9295 Tamara López-LópezDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0000-9345-907X Sebastian GrauteDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0002-1007-6298 Madeleine HamleyI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0009-0005-9418-8511 Joerg HeerenDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-5647-1034 Johann Von FeldenI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-2839-5174 Ansgar W LohseI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-8823-3129 Christoph SchrammI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4264-1928 Dorothee SchwingeI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0679-4476 Pablo J SáezDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0003-0521-9426 Samuel HuberI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-9325-8227 Thomas JacobsProtozoa Immunology, Bernhard Nocht Institute for Tropical Medicine , Hamburg, Germany.ORCID 0000-0003-3313-7866 Lorenz AdlungI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-0971-2309 Anna WorthmannDepartment of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-4731-3974 Lidia BosurgiI. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-8775-4950 Funding
Deutsche Forschungsgemeinschaft 335447717Deutsche Forschungsgemeinschaft 449437943Deutsche Forschungsgemeinschaft 450149205Deutsche Forschungsgemeinschaft 530990199Deutsche Forschungsgemeinschaft BO5198/7-1State of Hamburg LFF-FV78
6 · The paper itselfAbstract
The clearance of apoptotic cells by phagocytes is crucial for restoring tissue balance after injury. In autoimmune liver diseases like primary sclerosing cholangitis, cell death is thought to result from accumulation of toxic bile acids within parenchymal cells. Whether, in this context, bile acid-loaded dying cells impact the efficiency of phagocytic macrophages in restoring tissue balance remains unknown. Here, we demonstrate that in a murine model of cholangitis, bile acids accumulate in a subpopulation of efferocytic macrophages with pro-inflammatory features. Our in vitro results indicate that, upon their engulfment, apoptotic hepatocytes laden with bile acids can serve as Trojan horses, delivering bile acids into efferocytic macrophages and thereby shaping macrophage function. This contrasts with the characteristics of macrophages that engulf apoptotic parenchymal cells lacking bile acids. Together, our findings delineate a system in which the content of the phagocytosed dying cells, specifically bile acid-laden hepatocytes, drives a pro-inflammatory program in the corresponding efferocytic macrophages, potentially contributing to chronic hepatic inflammation.
Indexed as
Bile Acids and SaltsCholangitisInflammationMacrophagesAnimalsApoptosisDisease Models, AnimalEfferocytosisHepatocytesMiceMice, Inbred C57BLPhagocytosisBile Acids and Salts
Identifiers
PMID42334420
PMCPMC13289589
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390